Acelity Appoints Gaurav S. Agarwal as Group President, Businesses and Innovation
December 09, 2014 13:55 KST
SAN ANTONIO--(Business Wire / Korea Newswire) December 09, 2014 -- Acelity L.P. Inc. announced today the appointment of Gaurav S. Agarwal as Group President, Businesses and Innovation, a newly-created role on the Acelity senior leadership team reporting directly to Joe Woody, President & CEO. In this role, Gaurav will lead the strategic direction for all Acelity businesses, including Advanced Wound Therapeutics and Regenerative Medicine.
Gaurav will assume commercial responsibility for Acelity’s diverse product portfolio of innovative healing solutions and regenerative and reconstructive tissue matrices. He will drive Acelity’s product portfolio expansion to offer new and innovative solutions for the future of negative pressure therapies and adjacent technologies. Gaurav will oversee Acelity’s innovation pipeline, product portfolio strategy and execution, in addition to North American commercial operations. He will be responsible for creating and managing multiple development platforms across the business to continue to bring highly differentiated products, such as the CelluTome™ Epidermal Harvesting System, to market.
Gaurav brings to Acelity nearly two decades of global business management in the healthcare industry. Most recently, he served as President, Orthopaedic Reconstruction for the Advanced Surgical Devices Division at Smith & Nephew where he was responsible for leading global strategic marketing and product development for joint reconstruction, as well as US commercial operations. He joined Smith & Nephew as the chief operating officer of the Orthopaedic global business unit where he led initiatives to expedite the product development process and rationalize the product portfolio.
Having spent almost 15 years at GE Corporation in the company’s healthcare division, Gaurav has extensive experience establishing distribution channels on a global scale. During his time at GE, he was responsible for driving growth and commercial profitability for the company’s medical device business across Asia, including Japan and China. In addition to his commercial leadership experience, Gaurav served as Chief Technology, Quality, Regulatory and Strategy Officer, responsible for all technology and innovation initiatives for the $5 billion device business.
“Gaurav has valuable insight into global markets for medical devices and a demonstrated track record of driving commercial performance throughout the world,” said Joe Woody, President & CEO, Acelity. “His expertise and commercial leadership experience, coupled with his strong background in innovation and product portfolio management, will make him a tremendous asset to Acelity as we look to 2015 and beyond.”
Gaurav holds a Bachelor of Science degree in chemical engineering from Rensselaer Polytechnic Institute. He is a Six Sigma Quality Leader and is Six Sigma Black Belt certified.
Acelity is a global wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. We are committed to advancing the science of healing and restoring people’s lives. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,500 people around the world. We believe in enabling better futures for everyone. Please visit acelity.com.
- Apax Funds, CPPIB and PSP Investments Agree to Sell Acelity and its KCI Subsidiaries to 3M for $6.725 Billion
- KCI Files Registration Statement for Proposed Initial Public Offering
- Acelity L.P. Inc. Announces New Senior Leadership Appointments
- KCI Launches ABTHERA™ Therapy in Japan
- Acelity Enters Agreement to Transition Systagenix Manufacturing Facility to Scapa Healthcare